Slingshot members are tracking this event:
Aimmune (AIMT) Expects to Begin Open-Label Rollover Trial From PALISADE in Q4 2016 Evaluating AR101 in Treatment of Peanut Allergies: Follow-on Study named ARC004
Slingshot Insights Explained
Dec 08, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Open-label Rollover Trial, Arc004, Phase 3 Palisade Trial, Ar101, Peanut Allergies